메뉴 건너뛰기




Volumn 6, Issue 2, 2010, Pages 206-213

The impact of bivalirudin on percutaneous coronary intervention-related bleeding

Author keywords

Anticoagulation; Bleeding; Percutaneous coronary intervention

Indexed keywords

EPTIFIBATIDE; HEPARIN; HIRULOG; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

EID: 77956861582     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I2A33     Document Type: Article
Times cited : (19)

References (28)
  • 3
    • 35348913868 scopus 로고    scopus 로고
    • Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention from the REPLACE-2 Trial
    • DOI 10.1016/j.amjcard.2007.06.026, PII S0002914907014300
    • Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-1369. (Pubitemid 47576015)
    • (2007) American Journal of Cardiology , vol.100 , Issue.9 , pp. 1364-1369
    • Feit, F.1    Voeltz, M.D.2    Attubato, M.J.3    Lincoff, A.M.4    Chew, D.P.5    Bittl, J.A.6    Topol, E.J.7    Manoukian, S.V.8
  • 5
    • 38949179203 scopus 로고    scopus 로고
    • Periprocedural Bleeding and 1-Year Outcome after Percutaneous Coronary Interventions. Appropriateness of Including Bleeding as a Component of a Quadruple End Point
    • DOI 10.1016/j.jacc.2007.10.040, PII S073510970703745X
    • Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schomig A, Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690-697. (Pubitemid 351221218)
    • (2008) Journal of the American College of Cardiology , vol.51 , Issue.7 , pp. 690-697
    • Ndrepepa, G.1    Berger, P.B.2    Mehilli, J.3    Seyfarth, M.4    Neumann, F.-J.5    Schomig, A.6    Kastrati, A.7
  • 8
    • 7044239273 scopus 로고    scopus 로고
    • Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial
    • DOI 10.1016/j.jacc.2004.05.085, PII S0735109704016018
    • Cohen DJ, Lincoff AM, Lavelle TA, Chen HL, Bakhai A, Berezin RH, Jackman D, Sarembock IJ, Topol EJ. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. J Am Coll Cardiol. 2004;44:1792-1800. (Pubitemid 39424077)
    • (2004) Journal of the American College of Cardiology , vol.44 , Issue.9 , pp. 1792-1800
    • Cohen, D.J.1    Lincoff, A.M.2    Lavelle, T.A.3    Chen, H.-L.4    Bakhai, A.5    Berezin, R.H.6    Jackman, D.7    Sarembock, I.J.8    Topol, E.J.9
  • 10
    • 0030918995 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study
    • Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-1435.
    • (1997) Lancet , vol.349 , pp. 1429-1435
  • 11
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    • The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998;339:436-443.
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 14
    • 33745675382 scopus 로고    scopus 로고
    • Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial
    • DOI 10.1016/j.ahj.2005.09.007, PII S0002870305008628
    • Rajagopal V, Lincoff AM, Cohen DJ, Gurm HS, Hu T, Desmet WJ, Kleiman NS, Bittl JA, Feit F, Topol EJ. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J. 2006;152:149-154. (Pubitemid 43974721)
    • (2006) American Heart Journal , vol.152 , Issue.1 , pp. 149-154
    • Rajagopal, V.1    Lincoff, A.M.2    Cohen, D.J.3    Gurm, H.S.4    Hu, T.5    Desmet, W.J.6    Kleiman, N.S.7    Bittl, J.A.8    Feit, F.9    Topol, E.J.10
  • 15
    • 50249086970 scopus 로고    scopus 로고
    • Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial
    • White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol. 2008;52:807-814.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 807-814
    • White, H.D.1    Ohman, E.M.2    Lincoff, A.M.3    Bertrand, M.E.4    Colombo, A.5    McLaurin, B.T.6    Cox, D.A.7    Pocock, S.J.8    Ware, J.A.9    Manoukian, S.V.10    Lansky, A.J.11    Mehran, R.12    Moses, J.W.13    Stone, G.W.14
  • 18
    • 33947187284 scopus 로고    scopus 로고
    • Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    • DOI 10.1016/S0140-6736(07)60450-4, PII S0140673607604504
    • Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007;369:907-919. (Pubitemid 46400858)
    • (2007) Lancet , vol.369 , Issue.9565 , pp. 907-919
    • Stone, G.W.1    White, H.D.2    Ohman, E.M.3    Bertrand, M.E.4    Lincoff, A.M.5    McLaurin, B.T.6    Cox, D.A.7    Pocock, S.J.8    Ware, J.H.9    Feit, F.10    Colombo, A.11    Manoukian, S.V.12    Lansky, A.J.13    Mehran, R.14    Moses, J.W.15
  • 19
    • 39549111446 scopus 로고    scopus 로고
    • Quality-improvement research and informed consent
    • DOI 10.1056/NEJMp0800136
    • Miller FG, Emanuel EJ. Quality-improvement research and informed consent. N Engl J Med. 2008;358:765-767. (Pubitemid 351281639)
    • (2008) New England Journal of Medicine , vol.358 , Issue.8 , pp. 765-767
    • Miller, F.G.1    Emanuel, E.J.2
  • 24
    • 33747599590 scopus 로고    scopus 로고
    • Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
    • DOI 10.1161/CIRCULATIONAHA.106.612812, PII 0000301720060822000007
    • Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-782. (Pubitemid 44268228)
    • (2006) Circulation , vol.114 , Issue.8 , pp. 774-782
    • Eikelboom, J.W.1    Mehta, S.R.2    Anand, S.S.3    Xie, C.4    Fox, K.A.A.5    Yusuf, S.6
  • 26
    • 34250179783 scopus 로고    scopus 로고
    • Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry
    • DOI 10.1002/ccd.21087
    • Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007;69:961-966. (Pubitemid 46897929)
    • (2007) Catheterization and Cardiovascular Interventions , vol.69 , Issue.7 , pp. 961-966
    • Yatskar, L.1    Selzer, F.2    Feit, F.3    Cohen, H.A.4    Jacobs, A.K.5    Williams, D.O.6    Slater, J.7
  • 27
    • 0345872125 scopus 로고    scopus 로고
    • Arterial Puncture Closing Devices Compared with Standard Manual Compression after Cardiac Catheterization: Systematic Review and Meta-analysis
    • DOI 10.1001/jama.291.3.350
    • Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291:350-357. (Pubitemid 38101608)
    • (2004) Journal of the American Medical Association , vol.291 , Issue.3 , pp. 350-357
    • Koreny, M.1    Riedmuller, E.2    Nikfardjam, M.3    Siostrzonek, P.4    Mullner, M.5
  • 28
    • 33947326964 scopus 로고    scopus 로고
    • A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices
    • DOI 10.1016/j.ahj.2006.12.014, PII S0002870307000452
    • Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J. 2007;153:606-611. (Pubitemid 46440677)
    • (2007) American Heart Journal , vol.153 , Issue.4 , pp. 606-611
    • Arora, N.1    Matheny, M.E.2    Sepke, C.3    Resnic, F.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.